HLA-G and breast carcinoma: HRAS gene showed a hazard ratio (HR) = 9.53 (95% CI: 1.3–69.88) and log-rank p-value = 0.006 for breast cancer; indicating that the result was statistically significant (the relation between the high expression of HLA-G gene and greater survival rate).